![Robert Jotte presents how Adagrasib shows improvement in PFS and ORR in previously treated patients – Sarah Cannon Research Institute](https://oncodaily.com/pub/uploads/2024/06/Jotte-e1719595611165-1280x960.jpg)
Photo of Robert Jotte from rockymountaincancercenters.com
Jul 1, 2024, 14:03
Robert Jotte presents how Adagrasib shows improvement in PFS and ORR in previously treated patients – Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn:
“Significant advancements in NSCLC treatment! SCRI’s Dr. Robert Jotte presents how Adagrasib shows improvement in PFS and ORR over Docetaxel in previously treated patients. Watch his detailed discussion on ecancer.”
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 2, 2024, 18:11